Day Trading Goal
  • Investing
  • Economy
  • Editor’s Pick
  • Latest News
  • Investing
  • Economy
  • Editor’s Pick
  • Latest News
No Result
View All Result
Day Trading Goal
No Result
View All Result
Home Investing

Morgan Stanley turns more optimistic on Apple as iPhone outlook improves

admin by admin
August 16, 2025
in Investing
0
Morgan Stanley turns more optimistic on Apple as iPhone outlook improves
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Morgan Stanley has expressed renewed optimism about Apple Inc., citing stronger-than-expected iPhone demand in China and the potential for upward estimate revisions.

Analyst Erik Woodring wrote in a Thursday note that “the Apple story could be turning the corner,” driven by higher iPhone build forecasts and the possibility of valuation expansion.

Stronger iPhone builds in China fuel forecasts

According to Morgan Stanley’s China team, iPhone sales in the June quarter outperformed expectations, prompting an 8% increase in its September iPhone builds estimate.

This improvement stems from stronger-than-expected iPhone sell-through, which reduced channel inventory below normalized levels and created a larger restocking opportunity.

The revised build forecast is concentrated entirely on iPhone 16 (2 million units) and iPhone 16 Pro Max (2 million units) models.

Woodring noted that while the September quarter outlook has already factored in these improvements, it could signal more upside in the December quarter — a period that typically experiences greater volatility.

“Relative to our current 78 million December quarter iPhone shipment forecast, this could imply modest iPhone shipment upside, though we’ll be able to narrow this range next month when the iPhone 17 is officially launched,” he said.

AI integration still in development

Apple’s broader growth prospects also hinge on the rollout of Apple Intelligence, the company’s suite of artificial intelligence features.

Key functions, including an updated Siri with AI capabilities, have faced multiple delays since their initial announcement last year.

The company is expected to reveal details of its new iPhone model next month, which could align with further AI announcements.

Morgan Stanley believes forward iPhone unit and revenue growth expectations remain relatively muted, despite several positive factors.

These include elongated replacement cycles, pent-up demand, new form factors in development, and structural gross margin tailwinds.

Woodring also pointed out that pricing remains an “underappreciated lever” for both Apple’s products and services, noting that the company has not raised services prices in two years.

Market position and potential catalysts

Apple shares have fallen more than 7% in 2025, and according to Woodring, many institutional investors remain underweight the stock compared with other megacap technology peers.

He also highlighted that peak tariff risk has passed, regulation appears less of a near-term obstacle than previously feared, and Apple is trading in line with its trailing five-year average relative to the S&P 500.

While regulatory pressures persist as a long-term consideration, Morgan Stanley sees room for Apple to benefit from potential AI-related partnerships, which could serve as a catalyst for a breakout in the stock.

“In our view, Apple is one potential AI partnership away from breaking out,” Woodring concluded.

The note underscores a shift in sentiment among some Wall Street analysts, as policy clarity, product cycles, and improving demand dynamics give Apple fresh momentum heading into the second half of the year.

The next major update to investor expectations may come with the launch of the iPhone 17, expected to provide further visibility into both demand trends and the company’s AI strategy.

The post Morgan Stanley turns more optimistic on Apple as iPhone outlook improves appeared first on Invezz


Previous Post

Opendoor shares jump as CEO Carrie Wheeler resigns amid investor pressure

Next Post

Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

Next Post
Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • Trending
    • Comments
    • Latest
    Senate hopefuls jostle for high-stakes seat after Blackburn jumps into governor race

    Senate hopefuls jostle for high-stakes seat after Blackburn jumps into governor race

    August 7, 2025
    Swatch Group stock price has imploded: is it a good buy?

    Swatch Group stock price has imploded: is it a good buy?

    August 15, 2025
    Watches of Switzerland share price crashes to key support: buy the dip?

    Watches of Switzerland share price crashes to key support: buy the dip?

    August 15, 2025
    Here’s why the Rheinmetall share price will pop after earnings

    Here’s why the Rheinmetall share price will pop after earnings

    August 5, 2025
    Nu Holdings stock price forecast after earnings: still a bargain?

    Nu Holdings stock price forecast after earnings: still a bargain?

    0
    Bondi says all charges against doctor who allegedly destroyed COVID vaccines have been dropped

    Bondi says all charges against doctor who allegedly destroyed COVID vaccines have been dropped

    0
    Trump defends embattled AG Pam Bondi, says ‘nobody cares about’ Jeffrey Epstein

    Trump defends embattled AG Pam Bondi, says ‘nobody cares about’ Jeffrey Epstein

    0
    Could Butler happen again? Former Secret Service agents weigh in on political violence in 2025

    Could Butler happen again? Former Secret Service agents weigh in on political violence in 2025

    0
    Nu Holdings stock price forecast after earnings: still a bargain?

    Nu Holdings stock price forecast after earnings: still a bargain?

    August 16, 2025
    US stocks unchanged as retail sales data signals resilient consumer

    US stocks unchanged as retail sales data signals resilient consumer

    August 16, 2025
    Cisco shares drop over 2% after HSBC downgrade to Hold

    Cisco shares drop over 2% after HSBC downgrade to Hold

    August 16, 2025
    Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    August 16, 2025

    Recent News

    Nu Holdings stock price forecast after earnings: still a bargain?

    Nu Holdings stock price forecast after earnings: still a bargain?

    August 16, 2025
    US stocks unchanged as retail sales data signals resilient consumer

    US stocks unchanged as retail sales data signals resilient consumer

    August 16, 2025
    Cisco shares drop over 2% after HSBC downgrade to Hold

    Cisco shares drop over 2% after HSBC downgrade to Hold

    August 16, 2025
    Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    August 16, 2025

    Popular News

    Nu Holdings stock price forecast after earnings: still a bargain?

    Nu Holdings stock price forecast after earnings: still a bargain?

    August 16, 2025
    US stocks unchanged as retail sales data signals resilient consumer

    US stocks unchanged as retail sales data signals resilient consumer

    August 16, 2025

    Latest News

    • Nu Holdings stock price forecast after earnings: still a bargain?
    • US stocks unchanged as retail sales data signals resilient consumer
    • Cisco shares drop over 2% after HSBC downgrade to Hold
    • Buffett’s $1.6 bn bet lifts UnitedHealth to 16-yr high, but analysts urge caution before buying

    About DayTradingGoal

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 Daytradinggoal.com All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Economy
    • Editor’s Pick
    • Latest News

    Copyright © 2025 Daytradinggoal.com All Rights Reserved.